BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bionomics Released Quarterly Activities and Cashflow Report

Released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 31 December 2022 (Quarter) and up to the date of this annou...

January 31, 2023 | News

DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore functi...

January 25, 2023 | News

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program

Avance Clinical made the announcement at Biotech Showcase 2023 where the team is taking meetings via PartnershipOne. "Given this successful early adoption ...

January 11, 2023 | News

Aurisco cooperates with Cytiva to build its first Oligo FlexFactory for commercial production

Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year. ...

January 06, 2023 | News

Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19

GS221 has conducted 3 clinical trials. Current results of clinical trials show favorable safety and tolerance in the subjects. After administra...

January 02, 2023 | News

Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies

"This agreement with Yonghe represents a significant step for Ablaze in our efforts to optimize our preclinical and clinical development program for target...

December 28, 2022 | News

Brii Biosciences Provides Update on Strategic Clinical Development Progress

Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical h...

December 28, 2022 | News

Data Shows 50% of New Trials Have Sites in Asia Pacific

According to the new publication titled "State of the Global Biotech Landscape: Where the Opportunities Lie", demand for Asia Pacific trial sites is strong...

December 15, 2022 | News

GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering with Allozymes, a Singap...

December 07, 2022 | News

Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company

Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of its me...

November 02, 2022 | News

I Peace partners with the California Institute for Regenerative Medicine [CIRM]

I Peace has been providing GMP Induced Pluripotent Stem Cells (iPSC) for a variety of cell therapy developers and pharmaceutical companies in the pas...

November 02, 2022 | News

Emmes (Global CRO) rapidly expands in India

Global CRO’s India office reports surging growth from Western, regional and local trial customers Emmes – a global, full-se...

October 28, 2022 | News

Merck to Support Jacobio Pharma on Clinical Trial of JAB-21822 in Combination with Cetuximab

This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer. Jacobio ...

October 13, 2022 | News

Australia's Paradigm Biopharmaceuticals reports positive early osteoarthritis drug trial results

Australian repurposing drug company Paradigm Biopharmaceuticals says positive clinical trial results for its osteoarthritis drug candidate indicate a poten...

October 07, 2022 | News

Stay Connected